🇺🇸 MetMAb in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 6

Most-reported reactions

1. Death — 1 report (16.67%)
2. Deep Vein Thrombosis — 1 report (16.67%)
3. Haemorrhagic Tumour Necrosis — 1 report (16.67%)
4. Pleural Effusion — 1 report (16.67%)
5. Pneumothorax — 1 report (16.67%)
6. Pulmonary Embolism — 1 report (16.67%)

Source database →

Frequently asked questions

Is MetMAb approved in United States?

MetMAb does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for MetMAb in United States?

Genentech, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.